NASDAQ: NSPR - InspireMD, Inc.

Yield per half year: +4.09%
Dividend yield: 0.00%
Sector: Healthcare

Share chart InspireMD, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About InspireMD, Inc.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Delivery System, a mesh-covered self-expanding carotid stent; SwitchGuard, a non-invasive transcarotid artery revascularization device; and NGuard EPS for treating acute stroke with tandem lesions.

more details
The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2011-04-12
ISIN US45779A8466
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.inspiremd.com
Цена ао 2.87
Change price per day: -2.44% (2.87)
Change price per week: -1.41% (2.84)
Change price per month: -0.3559% (2.81)
Change price per 3 month: -5.08% (2.95)
Change price per half year: +4.09% (2.69)
Change price per year: +22.27% (2.29)
Change price per 3 year: +6.87% (2.62)
Change price per 5 year: +152.25% (1.11)
Change price per 10 year: 0% (2.8)
Change price per year to date: -6.67% (3)
All parameters

Underestimation

Title Value Grade
P/S 8.41 1
P/BV 1.32 9
P/E 40384.36 1
EV/EBITDA -2.06 0
Total: 5.25

Efficiency

Title Value Grade
ROA, % -41.8 0
ROE, % -50.42 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0772 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 67.7 8
Yield Ebitda, % 113.38 10
Yield EPS, % -98.86 0
Total: 7
More

Institutions Volume Share, %
Nantahala Capital Management, LLC 4132912 17.62
Orbimed Advisors LLC. 2133405 9.1
Marshall Wace LLP 1860405 7.93
Soleus Capital Management, L.P. 1378128 5.88
Rosalind Advisors, Inc. 925194 3.94
Velan Capital Investment Management LP 904029 3.85
PURA VIDA INVESTMENTS, LLC 450517 1.92
Millennium Management LLC 348274 1.48
Morgan Stanley 63530 0.27
Mesirow Financial Investment Management, Inc. 30000 0.13



Head Job title Payment Year of birth
Mr. Marvin L. Slosman President, CEO & Director 843.83k 1964 (61 year)
Mr. Craig Shore CFO, Chief Administrative Officer, Secretary & Treasurer 613.49k 1961 (64 years)
Mr. Andrea Tommasoli Chief Operating Officer 359.27k 1972 (53 years)
Mr. Amir Kohen Senior Vice President of Finance & HR N/A
Mr. Shane Thomas Gleason Chief Commercial Officer 486.04k 1975 (50 years)
Dr. Patrick A. Verta DVM, M.D., MS Stat Executive Vice President of Clinical & Medical Affairs N/A 1958 (67 years)
Dr. Sol J. Barer Ph.D. Special Advisor to the Board 13.92k 1947 (78 years)
Mr. Pete J. Ligotti Executive VP & GM of North America

Address: Israel, Tel Aviv, 4 Menorat Hamaor Street - open in Google maps, open in Yandex maps
Website: https://www.inspiremd.com